Cargando…

Morphologic Changes in Patient with Drusen and Drusenoid Pigment Epithelial Detachment after Intravitreal Ranibizumab for Choroidal Neovascular Membrane : A Case Report

The authors present a case of morphologic changes of drusen and drusenoid pigment epithelial detachment (DPED) after treating choroidal neovascularization (CNV) using ranibizumab in age-related macular degeneration (AMD). A 71-year-old woman has noticed mild visual acuity deterioration in the right...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sukjin, Oh, Jeongjae, Kim, Kiseok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780511/ https://www.ncbi.nlm.nih.gov/pubmed/27014379 http://dx.doi.org/10.2174/1874364101610010001

Ejemplares similares

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
por: Gallego-Pinazo, Roberto, et al.
Publicado: (2011)

Associations Between Retinal Pigment Epithelium and Drusen Volume Changes During the Lifecycle of Large Drusenoid Pigment Epithelial Detachments
por: Balaratnasingam, Chandrakumar, et al.
Publicado: (2016)

Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics
por: Shijo, Taiyo, et al.
Publicado: (2021)

Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment
por: Zhao, Chun, et al.
Publicado: (2016)

Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
por: Yamashita, Mariko, et al.
Publicado: (2014)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban, Abdallah A, et al.
Publicado: (2012)

Photodynamic Therapy Treatment for Eyes with Drusenoid Pigment Epithelium Detachment
por: Lee, Na Young, et al.
Publicado: (2008)

Autologous full-thickness RPE-choroid graft to treat high-risk drusenoid pigment epithelial detachment without CNV
por: Sillen, Hedwig, et al.
Publicado: (2020)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Shah, Nikunj J, et al.
Publicado: (2011)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Pandey, Neeraj, et al.
Publicado: (2013)

Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
por: Zafar, Sidra, et al.
Publicado: (2016)

ANATOMIC AND FUNCTIONAL IMPROVEMENT OF A DRUSENOID PIGMENT EPITHELIAL DETACHMENT: A CASE REPORT
por: Csaky, Karl G., et al.
Publicado: (2020)

Subretinal drusenoid deposits versus drusen on multicolor imaging
por: Venkatesh, Ramesh, et al.
Publicado: (2020)

Impact of drusen and drusenoid retinal pigment epithelium elevation size and structure on the integrity of the retinal pigment epithelium layer
por: Schlanitz, Ferdinand, et al.
Publicado: (2019)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
por: Fan, Chuanfeng, et al.
Publicado: (2014)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment
por: Shijo, Taiyo, et al.
Publicado: (2022)

Coats plus syndrome with new observation of drusenoid retinal pigment epithelial detachments in a teenager()
por: Agrawal, Kushal U., et al.
Publicado: (2022)

Comments on: Subretinal drusenoid deposits versus drusen on multicolor imaging
por: Ayachit, Apoorva, et al.
Publicado: (2021)

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
por: Makri, Olga E, et al.
Publicado: (2018)

Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma
por: H.Y. Wu, Zenith, et al.
Publicado: (2012)

The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
por: Kolomeyer, A. M., et al.
Publicado: (2011)

Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment
por: Yin, Houfa, et al.
Publicado: (2016)

Treatment of Punctate Inner Choroidopathy with Choroidal Neovascularization Using Corticosteroid and Intravitreal Ranibizumab
por: Wu, Wei, et al.
Publicado: (2018)

Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
por: Yun, Cheolmin, et al.
Publicado: (2016)

Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration
por: Kim, Min Seok, et al.
Publicado: (2020)

Response to comments on: Subretinal drusenoid deposits versus drusen on multicolor imaging
por: Venkatesh, Ramesh, et al.
Publicado: (2021)

Recurrence of Macular Hole Retinal Detachment after Intravitreal Ranibizumab Injection for the Treatment of Choroidal Neovascularization from the Remaining Macular Hole Edge
por: Otsuka, Keiko, et al.
Publicado: (2012)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
por: Morris, Rodney J, et al.
Publicado: (2011)

Surgical Treatment for a Full-Thickness Macular Hole That Developed on a Large Drusenoid Pigment Epithelial Detachment
por: Azuma, Kunihiro, et al.
Publicado: (2021)

Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
por: Bhurayanontachai, Patama, et al.
Publicado: (2011)

Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child
por: Gupta, Aditi, et al.
Publicado: (2014)

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization
por: Petrou, Petros, et al.
Publicado: (2013)

Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child
por: Özkaya, Abdullah, et al.
Publicado: (2016)

Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
por: Sarıgül Sezenöz, Almila, et al.
Publicado: (2017)

Intravitreal ranibizumab for choroidal neovascularization in a patient with angioid streaks and multiple evanescent white dots
por: Pece, Alfredo, et al.
Publicado: (2016)

Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab
por: Kumar, Nitin, et al.
Publicado: (2018)

Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
por: Yılmaz, Turgut, et al.
Publicado: (2017)

The morphology of choroidal neovascularization in chronic central serous chorioretinopathy presenting with flat, irregular pigment epithelium detachment
por: Azzolini, Claudio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_egfa4susu9uff6ccuu0lu9in37